There are increasing reports connecting the coronavirus disease 2019 (COVID‑19) vaccinations and adverse otological events. These events are mostly explained by the immunological effects or the recorded thrombotic consequences of the vaccinations. The inner ear is liable to be insulted by the thrombosis of the terminal auditory artery causing sudden sensorineural hearing loss (SSNHL). We reported two cases that suffered from SSNHL within 2 weeks after the first dose of the Oxford–AstraZeneca vaccine without any previous hearing problems. These cases showed severe–profound hearing loss in the audiological evaluation. The first case presented with a vestibular hypofunction in the affected ear and received a course of systemic corticosteroids, followed by anticoagulants (heparin). The second case, instead, received six intratympanic injections of corticosteroid, followed by hyperbaric oxygen therapy. The audiological function partially recovered after the treatment in both cases, with complete vertigo recovery in the first case. These results revealed a kind of similarity of the clinical course in COVID‑19‑ and non‑COVID‑19‑associated SSNHL. Hyperbaric therapy showed to be helpful for improving the prognosis
Sudden Hearing Loss Related to COVID‑19 Adenovirus Vector Vaccine? / Margani, Valerio; Covelli, Edoardo; Elfarargy1, Haitham H.; Bandiera, Giorgio; Filippi, Chiara; Buffoni, Antonella; Sabino, Luigi; Barbara, Maurizio; Monini, Simonetta. - In: SAUDI JOURNAL OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY. - ISSN 1319-8491. - (2023), pp. 1-3. [10.4103/sjoh.sjoh_56_22]
Sudden Hearing Loss Related to COVID‑19 Adenovirus Vector Vaccine?
Valerio Margani
;Edoardo Covelli;Giorgio Bandiera;Chiara Filippi;Maurizio Barbara;Simonetta Monini
2023
Abstract
There are increasing reports connecting the coronavirus disease 2019 (COVID‑19) vaccinations and adverse otological events. These events are mostly explained by the immunological effects or the recorded thrombotic consequences of the vaccinations. The inner ear is liable to be insulted by the thrombosis of the terminal auditory artery causing sudden sensorineural hearing loss (SSNHL). We reported two cases that suffered from SSNHL within 2 weeks after the first dose of the Oxford–AstraZeneca vaccine without any previous hearing problems. These cases showed severe–profound hearing loss in the audiological evaluation. The first case presented with a vestibular hypofunction in the affected ear and received a course of systemic corticosteroids, followed by anticoagulants (heparin). The second case, instead, received six intratympanic injections of corticosteroid, followed by hyperbaric oxygen therapy. The audiological function partially recovered after the treatment in both cases, with complete vertigo recovery in the first case. These results revealed a kind of similarity of the clinical course in COVID‑19‑ and non‑COVID‑19‑associated SSNHL. Hyperbaric therapy showed to be helpful for improving the prognosisFile | Dimensione | Formato | |
---|---|---|---|
Margani_Sudden-Hearing-Loss Related-to COVID‑19_2023 .pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
627.87 kB
Formato
Adobe PDF
|
627.87 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.